US Stock MarketDetailed Quotes

ANTX AN2 Therapeutics

Watchlist
  • 2.170
  • +0.180+9.05%
Close Jun 14 16:00 ET
  • 2.100
  • -0.070-3.23%
Post 19:03 ET
64.73MMarket Cap-864P/E (TTM)

AN2 Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

AN2 Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.56

+29.11%
Analyst Rating

Buy

May 31, 2024

AN2 Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--

Unlock Free Earnings Estimates

AN2 Therapeutics Earnings Reports

  • AN2 Therapeutics | 10-Q: Quarterly report

    May 14 16:19 ET

  • AN2 Therapeutics | 10-K/A: Annual report (Amendment)

    May 14 16:06 ET

  • AN2 Therapeutics | 10-K: Annual report

    Mar 29 16:28 ET

  • AN2 Therapeutics: Q3 2023 Earnings Report

    Nov 9, 2023 16:15 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: May 31, 2024

    Buy

    • Buy

      40.00%

    • Hold

      60.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg